Opto Circuits (India) on Wednesday informed the exchanges that its wholly-owned subsidiary Eurocor GmbH has received patent for bioresorbable stent, which is an alternative to the traditional vascular stent. The patent grant will bolster the extension of Eurocor’s product portfolio to include bioresorbable devices, capable of addressing significant new markets and customers globally. Shareholders of Opto Circuits will closely monitor the development.

Related Topics